Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan W Drijfhout

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
PNAS Nexus|July 30, 2025
Modulation of immunoglobulin G oligomerization by variable domain glycans: A mechanism to regulate complement activationRoxane Biersteker, Leoni Abendstein, Sanne van de Bovenkamp, et al.
European Journal of Immunology|July 10, 2013
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activationRodney A Rosalia, Esther D Quakkelaar, Anke Redeker, et al.
International Journal of Cancer|April 12, 2008
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasiaMuriel van den Hende, Mariëtte I E van Poelgeest, Jeanette M van der Hulst, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2023
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activationDouwe J Dijkstra, Fleur S van de Bovenkamp, Leoni Abendstein, et al.
Nature Structural & Molecular Biology|April 30, 2014
T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac diseaseJan Petersen, Veronica Montserrat, Jorge R Mujico, et al.
International Journal of Cancer|December 6, 2011
Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II studyRenee Vermeij, Ninke Leffers, Baukje-Nynke Hoogeboom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicityGemma G Kenter, Marij J P Welters, A Rob P M Valentijn, et al.
Science Translational Medicine|January 12, 2018
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilmsAnna de Breij, Martijn Riool, Robert A Cordfunke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapyEsther P M Tjin, Debby Konijnenberg, Gabrielle Krebbers, et al.
The Journal of Clinical Investigation|September 20, 2008
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeAnia Skowera, Richard J Ellis, Ruben Varela-Calviño, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
PNAS Nexus|July 30, 2025
Modulation of immunoglobulin G oligomerization by variable domain glycans: A mechanism to regulate complement activationRoxane Biersteker, Leoni Abendstein, Sanne van de Bovenkamp, et al.
European Journal of Immunology|July 10, 2013
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activationRodney A Rosalia, Esther D Quakkelaar, Anke Redeker, et al.
International Journal of Cancer|April 12, 2008
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasiaMuriel van den Hende, Mariëtte I E van Poelgeest, Jeanette M van der Hulst, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2023
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activationDouwe J Dijkstra, Fleur S van de Bovenkamp, Leoni Abendstein, et al.
Nature Structural & Molecular Biology|April 30, 2014
T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac diseaseJan Petersen, Veronica Montserrat, Jorge R Mujico, et al.
International Journal of Cancer|December 6, 2011
Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II studyRenee Vermeij, Ninke Leffers, Baukje-Nynke Hoogeboom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicityGemma G Kenter, Marij J P Welters, A Rob P M Valentijn, et al.
Science Translational Medicine|January 12, 2018
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilmsAnna de Breij, Martijn Riool, Robert A Cordfunke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapyEsther P M Tjin, Debby Konijnenberg, Gabrielle Krebbers, et al.
The Journal of Clinical Investigation|September 20, 2008
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeAnia Skowera, Richard J Ellis, Ruben Varela-Calviño, et al.
Pageof 14